New protein involved in prostate cancer
Nature Communications
2011년5월11일
The tumour suppressor protein PTEN is inactivated in many cancers including prostate cancer, now a protein, α-mannosidase 2C1, is shown to inactivate PTEN function in prostate cancer cells. These findings, reported in Nature Communications this week, enhance our knowledge of tumour development in prostate cancer.
The mechanisms leading to tumourigenesis are complex. Damu Tang and colleagues identify a protein, α-mannosidase 2C1, that can inactivate the tumour suppressor PTEN. The team injected prostate cancer cells over-expressing α-mannosidase 2C1 into mice and found that they formed tumours. They also show that human prostate tumours that express PTEN protein have high levels of α-mannosidase 2C1. Analysis of prostate cancer survival demonstrates that α-mannosidase 2C1 is associated with decreased recurrence free survival.
Further investigation of the role of α-mannosidase 2C1 in prostate cancer both in mice in the laboratory and in human samples is warranted to improve our understanding of this disease.
doi: 10.1038/ncomms1309
리서치 하이라이트
-
6월24일
Sport science: New wearable sensor to measure neck strain may detect potential concussionScientific Reports
-
6월23일
Scientific community: Women credited less than men in scientific paper authorshipNature
-
6월17일
Health technology: New cost-effective smartphone test for middle ear functionCommunications Medicine
-
6월16일
An exercise-inducible molecule that suppresses appetiteNature
-
6월16일
Cancer: Signatures of structural genomic variation in cancerNature
-
6월10일
Animals: Genetic clues to how dogs became man’s best friendsScientific Reports
